Application Information

This drug has been submitted to the FDA under the reference 022108/001.

Names and composition

"APLENZIN" is the commercial name of a drug composed of BUPROPION HYDROBROMIDE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
022108/001 APLENZIN BUPROPION HYDROBROMIDE TABLET, EXTENDED RELEASE/ORAL 174MG
022108/002 APLENZIN BUPROPION HYDROBROMIDE TABLET, EXTENDED RELEASE/ORAL 348MG
022108/003 APLENZIN BUPROPION HYDROBROMIDE TABLET, EXTENDED RELEASE/ORAL 522MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
022108/001 APLENZIN BUPROPION HYDROBROMIDE TABLET, EXTENDED RELEASE/ORAL 174MG
022108/002 APLENZIN BUPROPION HYDROBROMIDE TABLET, EXTENDED RELEASE/ORAL 348MG
022108/003 APLENZIN BUPROPION HYDROBROMIDE TABLET, EXTENDED RELEASE/ORAL 522MG
200835/001 BUPROPION HYDROBROMIDE BUPROPION HYDROBROMIDE TABLET, EXTENDED RELEASE/ ORAL 174MG
200835/002 BUPROPION HYDROBROMIDE BUPROPION HYDROBROMIDE TABLET, EXTENDED RELEASE/ ORAL 522MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved